Advertisement

Topics

Juvenescence Limited Company Profile

00:42 EDT 24th March 2019 | BioPortfolio

Juvenescence Limited is an investment company focussed on therapies to increase human longevity and complementary investments in related sectors. It was founded in 2017 by Jim Mellon, Greg Bailey,Declan Doogan, Anthony Chow, and Alexander Pickett. The Juvenescence team are highly experienced entrepreneurs and investors with a significant focus on the life science and commercial drug development sectors. Juvenescence creates new ventures and invests directly in both startup and established longevity related companies while offering strategic advice and operational support.


News Articles [44 Associated News Articles listed on BioPortfolio]

Juvenescence’s market watch

As it waits for the right moment to go public, Juvenescence keeps building its portfolio of aging-related assets.

Juvenescence closes first tranche of series B financing for further growth and development

Juvenescence intends to complete its $100 million Series B financing with the closing of a second tranche in Q1 2019. Juvenescence has now raised over $110 million in The post Juvenescence closes fir...

Tranched funding round raises $46M for Juvenescence

A first tranche round of Series B funding pulled in $46 million for Juvenescence, which invests in new companies that develop -More- 

#news #biotech Anti-aging startup Juvenescence bags $46M for pipeline push

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Anti-aging startup Juvenescence bags $46M for pipeline push .Juvenescence has...

Juvenescence gets initial $46mm of $100mm in Series B funding

Juvenescence Ltd. (therapies for age-related diseases) raised $46mm in the first tranche of its Series B financing. The round is expected to close at $100mm in Q1 2019. The company says the funds will...

Juvenescence Closes First Tranche of Series B Enabling Further Growth and Development

Juvenescence Ltd, a biopharmaceutical company focused on modifying ageing and age-related disease, is pleased to announce the close of the first tranche of its Series B financing,...

Juvenescence raises first tranche of $100M series B

Juvenescence, Buck Institute launch company to research ketones for age-related diseases

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Adenosine [wockhardt limited]

Adenosine Injection, USP FOR RAPID BOLUS INTRAVENOUS USE

Felodipine [wockhardt limited]

Felodipine Extended-Release Tablets, USP Rx only

Ranitidine [wockhardt limited]

Ranitidine Syrup (Ranitidine Oral Solution, USP)

Risperidone [wockhardt limited]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Amlodipine besylate [wockhardt limited]

These highlights do not include all the information needed to use amlodipine besylate tablets safely and effectively. See full prescribing information for amlodipine besylate tablets. Amlodipine Besyl...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

THE UROLOGY MATCH PROCESS AND THE LIMITED VALUE OF POST-INTERVIEW COMMUNICATION FOR PROGRAM DIRECTORS.

To understand the urology Match process from the perspective of residency program directors, with a particular focus on the role of post-interview communication. Recent surveys of urology applicants r...

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

Juvenescence Limited

Juvenescence Limited is an investment company focussed on therapies to increase human longevity and complementary investments in related sectors. It was founded in 2017 by Jim Mel...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Juvenescence Limited" on BioPortfolio

We have published hundreds of Juvenescence Limited news stories on BioPortfolio along with dozens of Juvenescence Limited Clinical Trials and PubMed Articles about Juvenescence Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Juvenescence Limited Companies in our database. You can also find out about relevant Juvenescence Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record